secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2022-12-20T23:59:59+00:00
Accession:  0001193125-22-309120
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 5.07, 2.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PBAX stockholders approve extension of business combination deadline to April 2023
--------------------------------------------------------------------------------

- Stockholders voted 20,111,798 for and 251,977 against the charter amendment extending the deadline.
- Charter amended to extend business combination period from Jan 8, 2023 to Apr 8, 2023, with up to three one-month extensions to July 8, 2023.
- Sponsor provided up to $1.5M promissory note; $325,000 deposited into trust for the first extension to Apr 8, 2023.
- Note is non-interest bearing, convertible into units at $10/unit upon a business combination, and repayable only from non-trust funds if no deal by July 8, 2023.
- Trust agreement amended to reflect the new deadlines and extension deposit requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000119312522309120/0001193125-22-309120-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000119312522309120/d423117d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-309120

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer